Ascletis Pharma Inc
HKEX:1672
Ascletis Pharma Inc
HKEX:1672
Price:
12.69
HKD
-8.04%
Market Closed
Market Cap:
HK$12.6B
Relative Value
The Relative Value of one
Ascletis Pharma Inc
stock under the Base Case scenario is
hidden
HKD.
Compared to the current market price of 12.69 HKD,
Ascletis Pharma Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Ascletis Pharma Inc Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Ascletis Pharma Inc Competitors
Ascletis Pharma Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Ascletis Pharma Inc
HKEX:1672
|
12.2B HKD | 4 600.9 | -42.1 | -23.4 | -23.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.7B USD | 6.7 | 169.6 | 16.4 | 23.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.7B USD | 5.1 | 26.1 | 18.7 | 18.7 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.8B USD | 6.2 | 22.1 | 15 | 15 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
117.6B USD | 10 | 32 | 23.5 | 24.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD | 5.5 | 17.6 | 14.9 | 17 | |
| AU |
|
CSL Ltd
ASX:CSL
|
86.7B AUD | 3.9 | 20.1 | 13.4 | 16.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.5B EUR | 14.5 | 34.2 | 58.4 | 60.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
